Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Study Finds Perception of Time Linked to Heartbeat
03/07/2023
Cornell University researchers found that our momentary perception of time is not continuous but may stretch or shrink with each heartbeat.
Cornell University researchers found that our momentary perception of time is not continuous but may stretch or shrink with each heartbeat.
Cornell University researchers...
03/07/2023
Cath Lab Digest
News
ACC.23: Medtronic PulseSelect PFA System Demonstrates Impressive Results in Landmark PULSED AF Global IDE Trial
03/06/2023
PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation.
PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation.
PULSED AF, one of the most...
03/06/2023
EP Lab Digest

Advertisement

News
ACC.23: 'Keto-Like’ Diet May Be Linked to Higher Risk of Heart Disease, Cardiac Events
03/06/2023
“Our study found that regular consumption of a self-reported diet low in carbohydrates and high in fat was associated with increased levels of LDL cholesterol and a higher risk of heart disease,” said Iulia Iatan, MD, PhD.
“Our study found that regular consumption of a self-reported diet low in carbohydrates and high in fat was associated with increased levels of LDL cholesterol and a higher risk of heart disease,” said Iulia Iatan, MD, PhD.
“Our study found that regular...
03/06/2023
Cath Lab Digest
News
ACC.23: Stick-on Device Provides Early Warning of Heart Failure Complications
03/06/2023
People with heart failure were 38% less likely to be readmitted to the hospital for heart failure complications within 90 days if they wore a stick-on sensor that alerted their clinician about fluid buildup in the lungs.
People with heart failure were 38% less likely to be readmitted to the hospital for heart failure complications within 90 days if they wore a stick-on sensor that alerted their clinician about fluid buildup in the lungs.
People with heart failure were...
03/06/2023
Cath Lab Digest
News
ACC.23: Bracelet Sensor Assesses Troponin Levels to Aid Heart Attack Diagnosis
03/06/2023
An experimental wrist-worn device was found to predict troponin-I and obstructed arteries with 90% accuracy in five minutes.
An experimental wrist-worn device was found to predict troponin-I and obstructed arteries with 90% accuracy in five minutes.
An experimental wrist-worn...
03/06/2023
Cath Lab Digest

Advertisement

News
ACC.23: New Ablation Technology Found Safe, Effective for Atrial Fibrillation
03/06/2023
Pulsed field ablation shortens operating times and may reduce the chance of damage to surrounding tissues.
Pulsed field ablation shortens operating times and may reduce the chance of damage to surrounding tissues.
Pulsed field ablation shortens...
03/06/2023
EP Lab Digest
News
ACC.23: Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients
03/06/2023
Amarin Corporation plc highlighted new in vitro data supporting the potential mechanistic effects of eicosapentaenoic acid (EPA) in reducing cardiovascular events in at-risk patients.
Amarin Corporation plc highlighted new in vitro data supporting the potential mechanistic effects of eicosapentaenoic acid (EPA) in reducing cardiovascular events in at-risk patients.
Amarin Corporation plc...
03/06/2023
Cath Lab Digest
News
ACC.23: Edwards Highlights New Data Related to Lifetime Management of Aortic Stenosis
03/06/2023
One study found that, for the almost 600,000 patients with AS severity assessment available, all degrees of untreated AS severity were associated with increased mortality risk.
One study found that, for the almost 600,000 patients with AS severity assessment available, all degrees of untreated AS severity were associated with increased mortality risk.
One study found that, for the...
03/06/2023
Cath Lab Digest

Advertisement

News
ACC.23: New VOYAGER PAD Analysis Confirms Consistent Benefit of Xarelto (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
03/05/2023
A new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforces the benefits of the XARELTO (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone),...
A new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforces the benefits of the XARELTO (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone),...
A new prespecified analysis from...
03/05/2023
Cath Lab Digest
News
ACC.23: Amarin Announces New REDUCE-IT Data Showing Benefit of Vascepa/Vazkepa (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event
03/05/2023
Amarin Corporation plc announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome...
Amarin Corporation plc announced a new analysis from the VASCEPA/VAZKEPA (icosapent ethyl) cardiovascular outcomes REDUCE-IT study showing the effectiveness of VASCEPA®/VAZKEPA® in patients with recent acute coronary syndrome...
Amarin Corporation...
03/05/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use